Juan Carlos Andreu-Ballester, Amparo Navarro, Miguel Angel Arribas, Moises Rico, Laura Albert, Carlos García-Ballesteros, Lorena Galindo-Regal, Rosa Sorando-Serra, Francisca López-Chuliá, Federico Peydro, Marta Rodero, Juan González-Fernández, Carmen Cuéllar
{"title":"脓毒症患者住院期间抗异尖线虫抗体水平升高","authors":"Juan Carlos Andreu-Ballester, Amparo Navarro, Miguel Angel Arribas, Moises Rico, Laura Albert, Carlos García-Ballesteros, Lorena Galindo-Regal, Rosa Sorando-Serra, Francisca López-Chuliá, Federico Peydro, Marta Rodero, Juan González-Fernández, Carmen Cuéllar","doi":"10.3390/antib13040096","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/objectives: </strong>In a previous study, we described elevated anti-<i>Anisakis</i> IgG levels in septic patients in relation to disease severity. In this study, our objective was to analyze the evolution of anti-<i>Anisakis</i> immunoglobulins in septic patients during hospital admission and their association with αβ and γδ T cell subsets.</p><p><strong>Methods: </strong>We recruited 80 subjects: 40 patients with sepsis and 40 controls. αβ and γδ T cells were analyzed using flow cytometry. Apoptosis was also assessed, and anti-<i>Anisakis</i> antibodies were measured by ELISA in the sera of patients with sepsis and controls.</p><p><strong>Results: </strong>In the second analysis (7-10 after sepsis evolution), an increase in all specific antibody isotypes was identified in individuals with septic shock, except IgE. The levels of anti-<i>Anisakis</i> IgG and IgA were higher in the subjects with sepsis in the first analysis and continued to increase in the second analysis compared with the healthy control subjects. There was an increase in anti-<i>Anisakis</i> IgG and IgA levels in surviving patients and an increase in IgA levels in non-surviving patients. A rise in specific IgG and IgE levels was noted in the second analysis of patients with sepsis with αβ CD3+ T cell deficiency. Patients without γδ T cell deficiency had increased anti-<i>Anisakis</i> IgA levels 7-10 days after admission.</p><p><strong>Conclusions: </strong>Our results suggest a previous infection by <i>Anisakis</i> that could be involved in the subsequent septic process and be related to patients who have negative cultures in which the pathogen causing sepsis has not been identified.</p>","PeriodicalId":8188,"journal":{"name":"Antibodies","volume":"13 4","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672462/pdf/","citationCount":"0","resultStr":"{\"title\":\"Increased Levels of Anti-<i>Anisakis</i> Antibodies During Hospital Admission in Septic Patients.\",\"authors\":\"Juan Carlos Andreu-Ballester, Amparo Navarro, Miguel Angel Arribas, Moises Rico, Laura Albert, Carlos García-Ballesteros, Lorena Galindo-Regal, Rosa Sorando-Serra, Francisca López-Chuliá, Federico Peydro, Marta Rodero, Juan González-Fernández, Carmen Cuéllar\",\"doi\":\"10.3390/antib13040096\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/objectives: </strong>In a previous study, we described elevated anti-<i>Anisakis</i> IgG levels in septic patients in relation to disease severity. In this study, our objective was to analyze the evolution of anti-<i>Anisakis</i> immunoglobulins in septic patients during hospital admission and their association with αβ and γδ T cell subsets.</p><p><strong>Methods: </strong>We recruited 80 subjects: 40 patients with sepsis and 40 controls. αβ and γδ T cells were analyzed using flow cytometry. Apoptosis was also assessed, and anti-<i>Anisakis</i> antibodies were measured by ELISA in the sera of patients with sepsis and controls.</p><p><strong>Results: </strong>In the second analysis (7-10 after sepsis evolution), an increase in all specific antibody isotypes was identified in individuals with septic shock, except IgE. The levels of anti-<i>Anisakis</i> IgG and IgA were higher in the subjects with sepsis in the first analysis and continued to increase in the second analysis compared with the healthy control subjects. There was an increase in anti-<i>Anisakis</i> IgG and IgA levels in surviving patients and an increase in IgA levels in non-surviving patients. A rise in specific IgG and IgE levels was noted in the second analysis of patients with sepsis with αβ CD3+ T cell deficiency. Patients without γδ T cell deficiency had increased anti-<i>Anisakis</i> IgA levels 7-10 days after admission.</p><p><strong>Conclusions: </strong>Our results suggest a previous infection by <i>Anisakis</i> that could be involved in the subsequent septic process and be related to patients who have negative cultures in which the pathogen causing sepsis has not been identified.</p>\",\"PeriodicalId\":8188,\"journal\":{\"name\":\"Antibodies\",\"volume\":\"13 4\",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-11-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672462/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antibodies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/antib13040096\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antibodies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/antib13040096","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Increased Levels of Anti-Anisakis Antibodies During Hospital Admission in Septic Patients.
Background/objectives: In a previous study, we described elevated anti-Anisakis IgG levels in septic patients in relation to disease severity. In this study, our objective was to analyze the evolution of anti-Anisakis immunoglobulins in septic patients during hospital admission and their association with αβ and γδ T cell subsets.
Methods: We recruited 80 subjects: 40 patients with sepsis and 40 controls. αβ and γδ T cells were analyzed using flow cytometry. Apoptosis was also assessed, and anti-Anisakis antibodies were measured by ELISA in the sera of patients with sepsis and controls.
Results: In the second analysis (7-10 after sepsis evolution), an increase in all specific antibody isotypes was identified in individuals with septic shock, except IgE. The levels of anti-Anisakis IgG and IgA were higher in the subjects with sepsis in the first analysis and continued to increase in the second analysis compared with the healthy control subjects. There was an increase in anti-Anisakis IgG and IgA levels in surviving patients and an increase in IgA levels in non-surviving patients. A rise in specific IgG and IgE levels was noted in the second analysis of patients with sepsis with αβ CD3+ T cell deficiency. Patients without γδ T cell deficiency had increased anti-Anisakis IgA levels 7-10 days after admission.
Conclusions: Our results suggest a previous infection by Anisakis that could be involved in the subsequent septic process and be related to patients who have negative cultures in which the pathogen causing sepsis has not been identified.
期刊介绍:
Antibodies (ISSN 2073-4468), an international, peer-reviewed open access journal which provides an advanced forum for studies related to antibodies and antigens. It publishes reviews, research articles, communications and short notes. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. Full experimental and/or methodical details must be provided. Electronic files or software regarding the full details of the calculation and experimental procedure - if unable to be published in a normal way - can be deposited as supplementary material. This journal covers all topics related to antibodies and antigens, topics of interest include (but are not limited to): antibody-producing cells (including B cells), antibody structure and function, antibody-antigen interactions, Fc receptors, antibody manufacturing antibody engineering, antibody therapy, immunoassays, antibody diagnosis, tissue antigens, exogenous antigens, endogenous antigens, autoantigens, monoclonal antibodies, natural antibodies, humoral immune responses, immunoregulatory molecules.